thromboprophylaxis

Advertisement
Patrick DalyVTE | September 6, 2023
According to a study published in Lancet, the optimal dose of low-molecular-weight heparin for venous thromboembolism ...
Patrick DalyVTE | September 6, 2023
Apixaban has been shown to be effective for preventing venous thromboembolism (VTE) in patients with cancer, but is ...
DocWire News EditorsVTE | September 6, 2023
Researchers from the Department of Medicine and the Ottawa Hospital Research Institute at the University of Ottawa in ...
Rob DillardThrombosis | September 6, 2023
The Jansen Pharmaceutical Companies of Johnson & Johnson recently announced new data from the Phase III UNIVERSE ...
Siddharth Singh, MDThrombosis | September 6, 2023
Editor's Note: This article was co-authored by Dr. Sabah Skaf, a cardiologist and Assistant Director of Echocardiography ...
Rob DillardVTE | September 6, 2023
Heart failure (HF) is an independent risk factor for venous thromboembolism (VTE), according to a study published in ...
DocWire News EditorsVTE | September 6, 2023
A new systematic review and meta-analysis indicates that there were no significant differences in venous thromboembolism ...
DocWire News EditorsDeep Vein Thrombosis | September 6, 2023
Asymptomatic proximal deep vein thrombosis (DVT) is still useful as a clinically relevant endpoint, results from a new ...
DocWire News EditorsVTE | September 6, 2023
A new analysis suggests that in patients with SARS-CoV-2 (COVID-19), the risk for venous thromboembolism (VTE) remained ...
DocWire News EditorsAHA Scientific Sessions 2020 | September 6, 2023
Patients in the intensive care unit (ICU) for COVID-19 had high rates of major arterial or venous thromboembolism (VTE), ...
Rob DillardCOVID-19 | September 11, 2023
Some Caucasian patients hospitalized with COVID-19 develop potentially deadly blood clotting in their lungs, according ...
Advertisement